Media Articles Related to Amerge (Naratriptan)
Migraine Linked to Mouth Bacteria
Source: Medscape NeurologyHeadlines [2016.10.21]
Researchers used data from a large microbiome project to identify and quantify bacteria species in the mouth that may explain the link between nitrate-based trigger foods and migraine.
Medscape Medical News
ANA: Exploring Management Links Between Migraine and CRPS (CME/CE)
Source: MedPageToday.com - medical news plus CME for physicians [2016.10.21]
(MedPage Today) -- Alleviating migraine co-morbidities may also help relieve complex regional pain
Could migraines be caused by the bacteria in our mouths?
Source: Biology / Biochemistry News From Medical News Today [2016.10.19]
Migraines have proven notoriously difficult to understand. New research points the finger at oral bacteria. Could the culprit have finally been found?
For Migraine Sufferers, Is a Chiropractor's Touch All in the Mind?
Source: MedicineNet Headache Specialty [2016.10.11]
Title: For Migraine Sufferers, Is a Chiropractor's Touch All in the Mind?
Category: Health News
Created: 10/11/2016 12:00:00 AM
Last Editorial Review: 10/11/2016 12:00:00 AM
Clinical trial tests spinal manipulation therapy for migraines
Source: Headache / Migraine News From Medical News Today [2016.10.04]
Manual-therapy randomized controlled trials (RCTs) are difficult to perform because it's challenging to conceal a placebo when patients are able to physically feel a treatment that's being...
Published Studies Related to Amerge (Naratriptan)
Published and not fully published double-blind, randomised, controlled trials
with oral naratriptan in the treatment of migraine: a review based on the GSK
Trial Register. 
Naratriptan 2.5Â mg is now an over-the-counter drug in Germany.Naratriptan, when available OTC is a reasonable second or third
choice on the step care ladder in the acute treatment of migraine.
Efficacy of oral naratriptan in the treatment of menstrually related migraine. [2005.10]
The aim of this study was to investigate the efficacy of orally administered 2.5 mg naratriptan in the treatment of menstrually related migraine (MRM). A high percentage of women suffering from migraine report increased frequency of attacks in association with menstruation that may be more severe, of longer duration and more difficult to treat than at other times...
Comparative efficacy of eletriptan vs. naratriptan in the acute treatment of migraine. [2003.11]
This was a randomized, double-blind study designed to evaluate the comparative efficacy and tolerability of the 40-mg dose of eletriptan and the 2.5-mg dose of naratriptan. Patients (n = 548) meeting International Headache Society (IHS) criteria for migraine were randomized to treat a single migraine attack with either eletriptan 40 mg, naratriptan 2.5 mg, or placebo.
Effects of naratriptan versus naproxen on daily functioning in the acute treatment of migraine: a randomized, double-blind, double-dummy, crossover study. [2003.09]
OBJECTIVE: To evaluate the effect of acute treatment on ictal behavioral functioning of patients with migraine via ambulatory accelerometry. BACKGROUND: The inability to carry out daily activities often complicates migraine attacks. Research into the effects of pharmacological drugs on this outcome parameter in the acute treatment of migraine has been based on subjective reports only... CONCLUSIONS: Consciously perceived clinical and subjective symptoms do not necessarily run in parallel with their behavioral equivalents. It, thus, may be important to assess the effects of treatment on behavioral functioning in the evaluation of the general efficacy of antimigraine drugs in the acute treatment of a migraine attack.
Naratriptan as short-term prophylaxis of menstrually associated migraine: a randomized, double-blind, placebo-controlled study. [2001.03]
OBJECTIVE: To determine the efficacy of naratriptan 1-mg and 2.5-mg tablets twice daily compared with placebo as short-term prophylaxis of menstrually associated migraine. BACKGROUND: Approximately 60% of women with migraine report headaches associated with their menstrual cycles. Results from an open-label study suggest that short-term administration of sumatriptan is useful in the prophylaxis of menstrually associated migraine... CONCLUSIONS: Naratriptan, 1 mg, with tolerability similar to placebo, is an effective, short-term, prophylactic treatment for menstrually associated migraine.
Clinical Trials Related to Amerge (Naratriptan)
Special Drug Use Investigation for AMERGEŽ Tablet (Long-term) [Completed]
To investigate the long-term safety and efficacy of AMERGE (naratriptan hydrochloride) on
Japanese patients with migraine headache in clinical setting
Naratriptan for the Treatment of Post Traumatic Headache Associated With Cognitive Dysfunction [Terminated]
The purpose of this study is to determine whether naratriptan, a medication approved for
treatment of migraine, is effective in the treatment of post traumatic headache associated
with cognitive dysfunction.
Drug Use Investigation for AMERGE (Naratriptan Hydrochloride) Tablet [Completed]
The study is designed to investigate the information on safety and efficacy of naratriptan
tablets on Japanese subjects with migraine headache during Japanese post-marketing
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine. [Not yet recruiting]
The purpose of this study is to determine whether a fixed-dose combination of naratriptan
2,5 mg + naproxen 500 mg is effective and safe compared each monotherapy for the acute
treatment of migraine.
Efficacy and Safety of a Fixed-dose Combination of Naratriptan and Naproxen in Acute Treatment of Migraine [Not yet recruiting]
The purpose of this study is to determine whether a fixed-dose combination of naratriptan +
naproxen is effective compared each monotherapy for the acute treatment of migraine.
Reports of Suspected Amerge (Naratriptan) Side Effects
Drug Ineffective (4),
Chest Pain (4),
Stress Cardiomyopathy (4),
Troponin T Increased (3),
Eye Pain (3),
Brain Natriuretic Peptide Increased (3),
Vasospasm (3), more >>